PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 27166928-6 2016 In addition, EPA and DHA enhanced the expression of leptin, adiponectin and apelin genes only in young cells. Eicosapentaenoic Acid 13-16 adiponectin, C1Q and collagen domain containing Mus musculus 60-71 30538803-9 2018 The DHA/EPA 2 : 1 group had lower serum levels of total cholesterol, triglycerides, and low-density lipoprotein cholesterol and higher levels of adiponectin than HFD group. Eicosapentaenoic Acid 8-11 adiponectin, C1Q and collagen domain containing Mus musculus 145-156 23550153-10 2013 Consumption of EPA dramatically reduced serum leptin (P < 0.02) and increased serum adiponectin in the AL-EPA mice compared with AL-Con mice (P < 0.001). Eicosapentaenoic Acid 15-18 adiponectin, C1Q and collagen domain containing Mus musculus 87-98 25816330-8 2015 Moreover, EPA treatment increased the otherwise reduced serum concentrations of adiponectin, an adipocytokine with anti-inflammatory and anti-fibrotic properties. Eicosapentaenoic Acid 10-13 adiponectin, C1Q and collagen domain containing Mus musculus 80-91 17569885-3 2007 METHODS AND RESULTS: We demonstrated that EPA increases adiponectin secretion in genetically obese ob/ob mice and high-fat diet-induced obese mice. Eicosapentaenoic Acid 42-45 adiponectin, C1Q and collagen domain containing Mus musculus 56-67 19277604-8 2009 RESULTS: DHA/EPA and rosiglitazone exerted additive effects in prevention of obesity, adipocyte hypertrophy, low-grade adipose tissue inflammation, dyslipidaemia and insulin resistance, while inducing adiponectin, suppressing hepatic lipogenesis and decreasing muscle ceramide concentration. Eicosapentaenoic Acid 13-16 adiponectin, C1Q and collagen domain containing Mus musculus 201-212 17717684-7 2008 The same reduction in levels of adiponectin gene expression was observed in epididymal adipose tissue of animals chronically fed soybean and coconut diets and in 3T3-L1 cells treated with palmitic, linoleic, EPA, and DHA acids. Eicosapentaenoic Acid 208-211 adiponectin, C1Q and collagen domain containing Mus musculus 32-43 23734181-0 2013 The eicosapentaenoic acid metabolite 15-deoxy-delta(12,14)-prostaglandin J3 increases adiponectin secretion by adipocytes partly via a PPARgamma-dependent mechanism. Eicosapentaenoic Acid 4-25 adiponectin, C1Q and collagen domain containing Mus musculus 86-97 23734181-3 2013 In our study, we show that eicosapentaenoic acid (EPA) increases secreted adiponectin from 3T3-L1 adipocytes and in plasma of mice as early as 4 days after initiation of an EPA-rich diet. Eicosapentaenoic Acid 27-48 adiponectin, C1Q and collagen domain containing Mus musculus 74-85 23734181-3 2013 In our study, we show that eicosapentaenoic acid (EPA) increases secreted adiponectin from 3T3-L1 adipocytes and in plasma of mice as early as 4 days after initiation of an EPA-rich diet. Eicosapentaenoic Acid 50-53 adiponectin, C1Q and collagen domain containing Mus musculus 74-85 20861209-7 2010 Further, plasma adiponectin concentration was lower in the HF group but was comparable in the LF and HF-EPA groups, suggesting a role of EPA in preventing and improving insulin resistance induced by HF feeding. Eicosapentaenoic Acid 137-140 adiponectin, C1Q and collagen domain containing Mus musculus 16-27 19416647-8 2009 When eicosapentaenoic acid (EPA), a suppressor of sterol regulatory element binding protein 1 (SREBP-1), was administered to HFHSD-fed mice, the sensitivity of DGalN, as a result of plasma ALT and AST levels, was suppressed accompanied by reduced plasma sTNFR2 level and hepatic levels of triglyceride, ROS, and fibrogenic parameters, and by increased plasma adiponectin levels. Eicosapentaenoic Acid 5-26 adiponectin, C1Q and collagen domain containing Mus musculus 359-370 19416647-8 2009 When eicosapentaenoic acid (EPA), a suppressor of sterol regulatory element binding protein 1 (SREBP-1), was administered to HFHSD-fed mice, the sensitivity of DGalN, as a result of plasma ALT and AST levels, was suppressed accompanied by reduced plasma sTNFR2 level and hepatic levels of triglyceride, ROS, and fibrogenic parameters, and by increased plasma adiponectin levels. Eicosapentaenoic Acid 28-31 adiponectin, C1Q and collagen domain containing Mus musculus 359-370 16397791-8 2006 EPA/DHA increased plasma adiponectin levels, independent of food intake, reflecting the stimulation of Adipoq expression in adipocytes and the release of adiponectin from WAT, particularly from epididymal fat. Eicosapentaenoic Acid 0-3 adiponectin, C1Q and collagen domain containing Mus musculus 25-36 16397791-2 2006 We tested whether the anti-diabetic effects of EPA and DHA involve enhanced production of the endogenous insulin sensitiser, adiponectin. Eicosapentaenoic Acid 47-50 adiponectin, C1Q and collagen domain containing Mus musculus 125-136 16397791-8 2006 EPA/DHA increased plasma adiponectin levels, independent of food intake, reflecting the stimulation of Adipoq expression in adipocytes and the release of adiponectin from WAT, particularly from epididymal fat. Eicosapentaenoic Acid 0-3 adiponectin, C1Q and collagen domain containing Mus musculus 103-109 16397791-8 2006 EPA/DHA increased plasma adiponectin levels, independent of food intake, reflecting the stimulation of Adipoq expression in adipocytes and the release of adiponectin from WAT, particularly from epididymal fat. Eicosapentaenoic Acid 0-3 adiponectin, C1Q and collagen domain containing Mus musculus 154-165 16397791-10 2006 CONCLUSIONS/INTERPRETATION: Intake of diets rich in EPA and DHA leads to elevated systemic concentrations of adiponectin, largely independent of food intake or adiposity and explain, to some extent, their anti-diabetic effects. Eicosapentaenoic Acid 52-55 adiponectin, C1Q and collagen domain containing Mus musculus 109-120